Search Login Register

Endometrioid Carcinoma Summary

417 relevant articles (5 outcomes, 51 trials/studies) found for this Disease

Description: An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.

Also Known As: Carcinoma, Endometrioid; Adenocarcinoma, Endometrioid; Endometrioid Adenocarcinoma; Adenocarcinomas, Endometrioid; Carcinomas, Endometrioid Show All >>

Key Drugs and Agents for Endometrioid Carcinoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Keratins (Keratin) : 2 outcomes 2 studies in 9 results : IBA
  2. Estrogens (Estrogen) : 1 outcome 4 studies in 31 results : FDA 1
  3. Inhibins (Inhibin) : 1 outcome 3 studies in 9 results : IBA
  4. Mucins : 1 outcome 1 study in 8 results : IBA
  5. Paclitaxel (Taxol) : 1 outcome in 3 results : FDA 12 Generic
  6. Carboplatin (JM8) : 1 outcome in 3 results : FDA 23 Generic
  7. Messenger RNA (mRNA) : 4 studies in 20 results : IBA
  8. beta Catenin : 3 studies in 29 results : IBA
  9. Paraffin : 3 studies in 24 results : IBA
  10. DNA (Deoxyribonucleic Acid) : 2 studies in 16 results : IBA
Show All >>

Diseases Related to Endometrioid Carcinoma

  1. Neoplasms (Cancer)
  2. Adenocarcinoma
  3. Carcinoma (Carcinomatosis)
  4. Neoplasm Metastasis (Metastasis)
  5. Hyperamylasemia
Show All >>

Key Therapies for Endometrioid Carcinoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome 2 studies in 9 results
  2. Hysterectomy : 2 studies in 35 results
  3. Lymph Node Excision (Lymph Node Dissection) : 2 studies in 10 results
  4. Curettage : 1 study in 12 results
  5. Appendectomy : 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.